Generics
Viatris names new CFO
28 February 2020 -

Viatris, the new company that will result from the planned combination of Mylan and Pfizer's Upjohn division, has named Sanjeev Narula as its new CFO, it was reported on Thursday.

Presently, Narula is Upjohn's chief financial officer. He has served Pfizer for 16 years and includes several financial leadership positions. He also has broad knowledge of the generic and branded pharmaceutical business, having earlier served as vice president, Finance, for Pfizer's Essential Health Business. Since joining Pfizer in 2004, Narula has also served as the Finance lead for the Primary Care Business Unit. Prior to joining Pfizer, he had financial and operational leadership roles at American Express and Xerox.

Pfizer chairman and CEO, Dr Albert Bourla, said, 'Sanjeev's global experience, proven leadership, and deep industry knowledge will serve Viatris employees, customers and shareholders well. I am very confident that his commitment to excellence will be instrumental as the new company charts its path as a champion for global health.'

Login
Username:

Password: